Join our daily newsletter At The Bell to receive exclusive market insights
The ASX is set to trade in the red today with ASX futures down 0.47 per cent near 8:30 am AEDT.
The Aussie bourse is likely to follow a soft US session that saw the S&P 500 down 0.39 per cent and the NASDAQ down 0.58 per cent.
In economics, we get trade data for both Australia and China today. People may try to divine where our trade relationship is heading from the releases.
We also get building approvals information for October here at home, and, population projections.
Here’s what stocks are catching eyes this morning:
Invictus Energy (ASX:IVZ) has reported a fresh gas discovery in Zimbabwe downhole Mukuyu-2.
The company has reported making the first “triassic aged hydrocarbon discovery in Sub-Saharan Africa.”
The company has also hinted at future “appraisal and exploration upside.”
Shares last traded at 16 cents.
Little Green Pharma (ASX:LGP) has expressed its new French cannabis strategy.
The update comes in the wake of new laws in France governing cannabis healthcare.
The French government has approved providers to continue supplying cannabis oil products within the country beyond a trial deadline originally set for Q1 2024.
Shares last traded at 12.5 cents.
In materials, Greentech Metals (ASX:GRE) has posted rock chip assay results from Kobe West.
The company’s peak rockchip sample came in at 2.3 per cent lithium.
Geotechs state that sampling confirms “significant lithium mineralisation at West end of Kobe trend.”
Shares last traded at 44 cents.
Imagion Biosystems (ASX:IBX) has posted “positive results” from its phase one study.
The company’s MagSense HER2 imaging agent has been found to be handled well by the human body.
The agent was used in the context of patients requiring lymph node scans after testing positive for HER2+ breast cancer.
Shares last traded at 34.5 cents.
And, Metals Australia (ASX:MLS) has kicked off a lithium exploration program at Warrambie.
The acreage is only 10 kilometres away from the well-known Azure Minerals (AZS) Andover project.
The company is on the hunt for spodumene in what it calls an “aggressive” fashion.
Shares last traded at 3.3 cents.
